You are here: Home Experience Mergers and Buy-side União Química

União Química

Date February, 2015
Client União Química
Counterparty Novartis
Industry Pharmaceutical
Amount Not disclosed

Landmark Capital acted as exclusive financial advisor of União Química Farmacêutica Nacional, one of Brazil´s biggest pharmaceutical companies, in the acquisition of a manufacturing site from Novartis, one of world´s biggest pharmaceuticals. This plant manufactures medicines to supply the Latin American market.

Besides the acquisition of the asset, the transaction also included a long term manufacturing agreement of Novartis medicines by União Química.